GLP-1 drugs such as Ozempic and Wegovy are providing new challenges for diet brands and gyms, who have seen a surge in demand ...

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

Glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, have dominated headlines for their ...

As GLP-1 drugs such as Ozempic™, Wegovy™, and Zepbound™ become more widely prescribed for obesity, Digbi Health's research addresses common challenges associated with these medications, including ...

Eli Lilly (LLY) weight loss therapy tirzepatide is on track to launch across England’s National Health Service ((NHS)) as ...

Whether a drug that selectively targets fat mass, with modest weight loss, translates into CV benefits awaits further study.

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

After 19 weeks on daily oral HU6 treatment, people shed on average 2.9 kg (~6.3 lb) or 2.7% of their starting body weight relative to placebo, both significant changes supporting some efficacy of the ...

Viking Therapeutics (NASDAQ: VKTX) has captured the attention of investors, with its stock price skyrocketing over 400% in one year.

With the launch of their new initiative, Hims & Hers is putting our community heroes first in line, offering a 50% discount on compounded GLP-1 weight loss medications to U.S. Military members, ...

Rice University's Biotech Launch Pad will lead the commercialization effort for "Rx On-site Generation Using Electronics" (ROGUE), a self-contained, durable implantable device that houses cells ...